Optimizing the Effect of COPD Rehabilitation

This study is not yet open for participant recruitment.

Verified by Glostrup University Hospital,Copenhagen, January 2007

First Received: January 4, 2007 No Changes Posted

Sponsor:	Glostrup University Hospital,Copenhagen
Collaborator:	Ministry of the Interior and Health, Denmark
Information provided by:	Glostrup University Hospital,Copenhagen
ClinicalTrials.gov Identifier:	NCT00419289

Purpose

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Condition	Intervention
Chronic Obstructive Pulmonary Disease	Behavioral: follow-up rehabilitation of participants with COPD

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study
Official Title:	Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation

Resource links provided by NLM:

MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease) Rehabilitation

U.S. FDA Resources

Further study details as provided by Glostrup University Hospital,Copenhagen:

Primary Outcome Measures:

Disease specific Quality of Life
Work Capacity

Secondary Outcome Measures:

Number of days admitted to hospital

Estimated Enrollment:	120
Study Start Date:	January 2007
Estimated Study Completion Date:	June 2008

Detailed Description:

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine. However, the effect of programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

FEV1 < 60% of expected

Exclusion Criteria:

Other severe chronic conditions

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00419289

Contacts

Contact: Susanne Vest, MD		susanne.vest@dadlnet.dk
Contact: Allan Linneberg, MD		alli@glostruphosp.kbhamt.dk

Locations

Denmark
Department of Internal Medicine M, Glostrup University Hospital
Copenhagen, Denmark, 2600

Sponsors and Collaborators

Glostrup University Hospital,Copenhagen

Ministry of the Interior and Health, Denmark

Investigators

Principal Investigator:

Susanne Vest, MD

Glostrup University Hospital,Copenhagen

More Information

No publications provided

Study ID Numbers:	KA20060179
Study First Received:	January 4, 2007
Last Updated:	January 4, 2007
ClinicalTrials.gov Identifier:	NCT00419289 History of Changes
Health Authority:	Denmark: Ethics Committee

Keywords provided by Glostrup University Hospital,Copenhagen:

COPD, rehabilitation, quality of life

Additional relevant MeSH terms:

Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on November 05, 2009